What does this research mean for the field?

SGLT2 inhibitors modulate arterial stiffness and cardiovascular disease risk in patients with diabetes mellitus. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 2021

Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i

Key Result

SGLT2 inhibitors modulate arterial stiffness and cardiovascular disease risk in patients with diabetes mellitus.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Bentham Science - STM publisher of online and print journals, and related print/online book series. Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences.

KI fragen

Bookmark

Cite This Study

Olga Lamacchia (Fri,) reported a other. SGLT2 inhibitors modulate arterial stiffness and cardiovascular disease risk in patients with diabetes mellitus.

synapsesocial.com/papers/6a1789b07afe20c06351e0cf https://doi.org/https://doi.org/10.2174/18756212mta1amziwy

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark